BFM
ELV icon

Boothbay Fund Management’s Elevance Health ELV Stock Holding History

Boothbay Fund Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,000
Closed -$454K – 2105
2022
Q3 		$454K Buy
1,000
+500
+100% +$239K 0.01% 1280
2022
Q2 		$241K Sell
500
-300
-38% -$148K 0.01% 1603
2022
Q1 		$393K Buy
+800
New +$366K 0.01% 1437

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Boothbay Fund Management's ELV Position: Q2 2026 in Review

Boothbay Fund Management increased its Elevance Health (ELV) stake by 281% in Q2 2026, buying an estimated $1.64M and bringing the position to 6,000 shares worth $2.32M. The position accounts for 0.03% of the portfolio, ranked #661.

Boothbay Fund Management first reported a position in ELV in Q4 2015 and has held it in 15 quarters since. The position peaked at $5.33M in Q4 2022. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Boothbay Fund Management held 6,000 shares of Elevance Health worth $2.32M as of Q2 2026.
  • Boothbay Fund Management bought 4,426 Elevance Health shares in Q2 2026, an estimated $1.64M.
  • Elevance Health made up 0.03% of Boothbay Fund Management's portfolio in Q2 2026, its #661 holding.
  • Boothbay Fund Management first reported a position in Elevance Health in Q4 2015 and has held it in 15 quarters since.
  • Boothbay Fund Management's Elevance Health position peaked at $5.33M in Q4 2022.
  • 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.